Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Barbato

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Blood|November 2, 2021
How I treat high-risk multiple myelomaElena Zamagni, Simona Barbato, Michele Cavo
International Review of Cell and Molecular Biology|July 22, 2017
MicroRNAs in Oncogenesis and Tumor SuppressionSimona Barbato, Giancarlo Solaini, Muller Fabbri
Recenti Progressi in Medicina|November 17, 2024
Lorella Salce, Simona Barbato, Francesco Bianchini, et al.
Journal of Clinical Medicine|November 4, 2020
Role of Imaging in the Evaluation of Minimal Residual Disease in Multiple Myeloma PatientsElena Zamagni, Paola Tacchetti, Simona Barbato, et al.
The Journal of Biological Chemistry|January 22, 2015
The inhibitor protein (IF1) of the F1F0-ATPase modulates human osteosarcoma cell bioenergeticsSimona Barbato, Gianluca Sgarbi, Giulia Gorini, et al.
Cancers|July 13, 2024
Bispecific Antibodies for the Management of Relapsed/Refractory Multiple MyelomaPaola Tacchetti, Simona Barbato, Katia Mancuso, et al.
Sensors (Basel, Switzerland)|January 8, 2025
New Challenges in Bladder Cancer Diagnosis: How Biosensing Tools Can Lead to Population Screening OpportunitiesFabiana Tortora, Antonella Guastaferro, Simona Barbato, et al.
Expert Opinion on Biological Therapy|December 9, 2024
Idecabtagene vicleucel (ide-cel) for the treatment of triple-class exposed relapsed and refractory multiple myelomaKatia Mancuso, Simona Barbato, Marco Talarico, et al.
Cancers|May 14, 2025
T-Cell Redirecting Therapies in Multiple Myeloma: Pathogenesis and Management of Toxicities Beyond CRS and ICANSKatia Mancuso, Marco Talarico, Enrica Manzato, et al.
Expert Review of Hematology|October 4, 2021
Emerging and current treatment combinations for transplant-ineligible multiple myeloma patientsPaola Tacchetti, Serena Rocchi, Simona Barbato, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Blood|November 2, 2021
How I treat high-risk multiple myelomaElena Zamagni, Simona Barbato, Michele Cavo
International Review of Cell and Molecular Biology|July 22, 2017
MicroRNAs in Oncogenesis and Tumor SuppressionSimona Barbato, Giancarlo Solaini, Muller Fabbri
Recenti Progressi in Medicina|November 17, 2024
Lorella Salce, Simona Barbato, Francesco Bianchini, et al.
Journal of Clinical Medicine|November 4, 2020
Role of Imaging in the Evaluation of Minimal Residual Disease in Multiple Myeloma PatientsElena Zamagni, Paola Tacchetti, Simona Barbato, et al.
The Journal of Biological Chemistry|January 22, 2015
The inhibitor protein (IF1) of the F1F0-ATPase modulates human osteosarcoma cell bioenergeticsSimona Barbato, Gianluca Sgarbi, Giulia Gorini, et al.
Cancers|July 13, 2024
Bispecific Antibodies for the Management of Relapsed/Refractory Multiple MyelomaPaola Tacchetti, Simona Barbato, Katia Mancuso, et al.
Sensors (Basel, Switzerland)|January 8, 2025
New Challenges in Bladder Cancer Diagnosis: How Biosensing Tools Can Lead to Population Screening OpportunitiesFabiana Tortora, Antonella Guastaferro, Simona Barbato, et al.
Expert Opinion on Biological Therapy|December 9, 2024
Idecabtagene vicleucel (ide-cel) for the treatment of triple-class exposed relapsed and refractory multiple myelomaKatia Mancuso, Simona Barbato, Marco Talarico, et al.
Cancers|May 14, 2025
T-Cell Redirecting Therapies in Multiple Myeloma: Pathogenesis and Management of Toxicities Beyond CRS and ICANSKatia Mancuso, Marco Talarico, Enrica Manzato, et al.
Expert Review of Hematology|October 4, 2021
Emerging and current treatment combinations for transplant-ineligible multiple myeloma patientsPaola Tacchetti, Serena Rocchi, Simona Barbato, et al.
Pageof 3